An Act establishing a pilot program for access to regulated psilocybin
Committee recommended bill ought to pass and referred to the committee on House Ways and Means
Email me when H 2203 moves
Committee action, floor votes, amendments and hearings. Free, no card, no password.
Already have an account? Track H 2203. By continuing you agree to the Terms and Privacy Policy.
Legislative status
- Introduced
- In Committee
- Reported by Committee
- Floor Vote Scheduled
- Passed One Chamber
- Passed Both Chambers
- Sent to Executive
- Signed into Law
Summary
The bill sets up a pilot program that would let qualified participants obtain psilocybin under state regulation. It targets patients, healthcare providers, and regulators who would oversee and study the program. The goal is to gather information on safety and therapeutic potential before any broader policy changes.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Ask about H 2203
3 free questions a day, no accountHearings
- Treatment Settings and PsychedelicsJoint Committee on Mental Health, Substance Use and Recovery · Nov 10, 2025
History
- Reporting date extended to Thursday, December 31, 2026
- Reported favorably by committee and referred to the committee on Health Care Financing
- Reporting date extended to Wednesday, March 18, 2026
- Hearing scheduled for 11/10/2025 from 01:00 PM-05:00 PM in A-2
- Senate concurred
- Referred to the committee on Mental Health, Substance Use and Recovery
Sponsors
- Marjorie C. Decker (D) · sponsor
- Estela A. Reyes
Similar bills in other states
Loading the map of where bills like this one were filed.
Share
Writing about this bill? Add a live status widget to your site or newsletter. It updates as the bill moves.
Track this bill
Get an email when H 2203 moves: committee action, floor votes, amendments and hearings. Free, no card.
Track H 2203 freeOr ask your AI assistant about H 2203 directly:
Add to Claude, ChatGPT or Cursor